📣 VC round data is live. Check it out!

HeartBeam Valuation Multiples

Discover HeartBeam's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Nortech Systems, MeVis, Accuray, SciBase Holding and more.

HeartBeam Overview

About HeartBeam

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company’s ability to develop higher-resolution ECG solutions is achieved through the development of the Company’s proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.


Founded

2015

HQ

United States

Employees

21

Financials (LTM)

Revenue: $412K
Net Income: ($20M)

EV

$47M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

HeartBeam Financials

HeartBeam reported last 12-month revenue of $412K.

In the same LTM period, HeartBeam generated $294K in gross profit and had net loss of ($20M).

Revenue (LTM)


HeartBeam P&L

In the most recent fiscal year, HeartBeam reported revenue of - and EBITDA of ($21M).

HeartBeam is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.

See analyst estimates for HeartBeam
LTMLast FY202320242025202620272028
Revenue$412K----
Gross Profit$294K----
Gross Margin71%----
EBITDA-($21M)($15M)($20M)($21M)
EBIT Margin(4987%)----
Net Profit($20M)($21M)($15M)($19M)($21M)
Net Margin(4926%)----

Financial data powered by Morningstar, Inc.

HeartBeam Stock Performance

HeartBeam has current market cap of $49M, and enterprise value of $47M.

Market Cap Evolution


HeartBeam's stock price is $0.88.

HeartBeam share price decreased by 0.4% in the last 30 days, and by 29.5% in the last year.

HeartBeam has an EPS (earnings per share) of $-0.38.

See more trading valuation data for HeartBeam
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$47M$49M-0.9%-0.4%-28.1%-29.5%$-0.38

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

HeartBeam Valuation Multiples

HeartBeam trades at 113.1x EV/Revenue multiple, and (2.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for HeartBeam

EV / Revenue (LTM)


HeartBeam Financial Valuation Multiples

As of June 3, 2026, HeartBeam has market cap of $49M and EV of $47M.

HeartBeam has a P/E ratio of (2.4x).

LTMLast FY202320242025202620272028
EV/Revenue113.1x----
EV/EBITDA-(2.2x)(3.0x)(2.3x)(2.2x)
EV/EBIT(2.3x)(2.2x)(3.0x)(2.3x)(2.2x)
EV/Gross Profit158.2x----
P/E(2.4x)(2.3x)(3.3x)(2.5x)(2.3x)
EV/FCF-(3.2x)(3.8x)(3.2x)(3.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified HeartBeam Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

HeartBeam Margins & Growth Rates

HeartBeam decreased net profit by 8% in the last fiscal year.

See estimated margins and future growth rates for HeartBeam

HeartBeam Margins

2026202720282029
Gross Margin71%
EBIT Margin(2022%)
Net Margin(1977%)

HeartBeam Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
EBITDA Growth-30%6%-
EBIT Growth(7%)30%6%(7%)
Net Profit Growth(8%)33%8%(8%)
FCF Growth-19%(1%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

HeartBeam Operational KPIs

HeartBeam's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.0M for the same period.

Access forward-looking KPIs for HeartBeam
LTMLast FY202620272028
Revenue per Employee-$0.0M
Opex per Employee-$1.0M
S&M Expenses to Revenue410%-
G&A Expenses to Revenue1962%-
R&D Expenses to Revenue3090%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

HeartBeam Competitors

HeartBeam competitors include Nortech Systems, MeVis, Accuray, SciBase Holding, Singular Health, InspireMD, K Pharma, Sensus Healthcare, Biohit and Elutia.

Most HeartBeam public comparables operate across Medical Devices, Medical Imaging & Diagnostics, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Nortech Systems0.6x-28.8x-
MeVis2.4x-11.3x-
Accuray0.4x0.5x6.8x63.8x
SciBase Holding10.2x8.1x(5.0x)(5.5x)
Singular Health288.8x-(9.6x)-
InspireMD1.0x0.9x(0.2x)(0.2x)
K Pharma--(7.0x)-
Sensus Healthcare1.1x1.1x(3.0x)(2.9x)

This data is available for Pro users. Sign up to see all HeartBeam competitors and their valuation data.

Start Free Trial

HeartBeam VC Funding History

Before going public, HeartBeam raised $23M in total equity funding, across 1 round.


HeartBeam Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
May-23Secondary - public-$23M--

Acquisitions by HeartBeam

HeartBeam has acquired 1 company to date.

Last acquisition by HeartBeam was on March 14th 2023. HeartBeam acquired LIVMOR for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by HeartBeam

LIVMOR
Description
LIVMOR is a digital health company delivering remote patient monitoring platforms that track physiological biomarkers such as blood pressure, heart rate, and blood glucose for chronic conditions including hypertension and diabetes. Its FDA-cleared devices integrate with cellular connectivity for seamless data transmission to healthcare providers. Based in San Francisco, LIVMOR partners with clinics and health systems across the United States to enable proactive interventions and reduce hospital readmissions. The platform supports HIPAA-compliant data security and features patient engagement tools like educational content and reminders.
HQ CountryUnited States
HQ City
Dallas, TX
Deal Date14 Mar 2023
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all HeartBeam acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About HeartBeam

When was HeartBeam founded?HeartBeam was founded in 2015.
Where is HeartBeam headquartered?HeartBeam is headquartered in United States.
How many employees does HeartBeam have?As of today, HeartBeam has over 21 employees.
Who is the CEO of HeartBeam?HeartBeam's CEO is Robert P. Eno.
Is HeartBeam publicly listed?Yes, HeartBeam is a public company listed on Nasdaq.
What is the stock symbol of HeartBeam?HeartBeam trades under BEAT ticker.
When did HeartBeam go public?HeartBeam went public in 2021.
Who are competitors of HeartBeam?HeartBeam main competitors include Nortech Systems, MeVis, Accuray, SciBase Holding, Singular Health, InspireMD, K Pharma, Sensus Healthcare, Biohit, Elutia.
What is the current market cap of HeartBeam?HeartBeam's current market cap is $49M.
What is the current revenue of HeartBeam?HeartBeam's last 12 months revenue is $412K.
What is the current revenue growth of HeartBeam?HeartBeam revenue growth (NTM/LTM) is 610%.
What is the current EV/Revenue multiple of HeartBeam?Current revenue multiple of HeartBeam is 113.1x.
Is HeartBeam profitable?No, HeartBeam is not profitable.
What is the current net income of HeartBeam?HeartBeam's last 12 months net income is ($20M).
How many companies HeartBeam has acquired to date?As of June 2026, HeartBeam has acquired 1 company.
What was the largest acquisition by HeartBeam?None of the M&A deals HeartBeam has completed have disclosed valuations.
What companies HeartBeam acquired?HeartBeam acquired LIVMOR.
In how many companies HeartBeam has invested to date?HeartBeam hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to HeartBeam

Lists including HeartBeam

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial